Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|10|1|1-7
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.10, Iss.1, 2010-03, pp. : 1-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Imatinib mesylate promising for CML
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Access to resources
Recommend
Targeted therapy of hepatocellular cancer
Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. :
Endoglin-Targeted Cancer Therapy
Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. :
Targeted Therapy of Breast Cancer
Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. :